NanoViricides
NNVC • AMEX
NanoViricides is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Anil R. Diwan, with a market cap of $19.0M.
CEOAnil R. Diwan
Market Cap$19.0M
Biotechnology
Healthcare
Employees7.0
Websitenanoviricides.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for NanoViricides
Date
Friday, February 20, 2026 (in 1 week)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.10
Earnings History
Past 12 earnings reports for NanoViricides
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q1 2026 | -$0.10Est: -$0.16 | +37.5% | - | — |  10-Q |
| Sep 29, 2025 | Q4 2025 | -$0.13 | — | - | — | 10-K |
| May 15, 2025 | Q3 2025 | -$0.14 | — | - | — | 10-Q |
| Feb 14, 2025 | Q2 2025 | -$0.14 | — | - | — | 10-Q |
| Nov 14, 2024 | Q1 2025 | -$0.23 | — | - | — | 10-Q |
| Sep 27, 2024 | Q4 2024 | -$0.19 | — | - | — | 10-K |
| May 15, 2024 | Q3 2024 | -$0.16Est: -$0.19 | +15.8% | - | — | 10-Q |
| Feb 14, 2024 | Q2 2024 | -$0.18 | — | - | — | 10-Q |
| Nov 14, 2023 | Q1 2024 | -$0.17 | — | - | — | — |
| Oct 13, 2023 | Q4 2023 | -$0.31Est: -$0.17 | -82.4% | - | — | 10-K |
| May 15, 2023 | Q3 2023 | -$0.15 | — | - | — | 10-Q |
| Feb 14, 2023 | Q2 2023 | -$0.15Est: -$0.16 | +6.3% | - | — | — |